Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 03, 2013 16:01 ET | Source: Endologix

Endologix Announces Offering of $75 Million of Convertible Notes

IRVINE, Calif., Dec. 3, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX) ("Endologix" or the "Company") today announced that it intends, subject to market and other conditions, to offer $75...
November 25, 2013 16:15 ET | Source: Endologix

Endologix to Participate in Two Investor Conferences in December

IRVINE, Calif., Nov. 25, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Shelley Thunen, Chief...
November 12, 2013 09:00 ET | Source: Endologix

Endologix to Host Investor Meeting on Wednesday, November 20, 2013

IRVINE, Calif., Nov. 12, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today details for its 2013 investor...
November 05, 2013 16:05 ET | Source: Endologix

Endologix to Present at the Stephens Fall Investment Conference

IRVINE, Calif., Nov. 5, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Shelley Thunen, Chief...
October 30, 2013 16:05 ET | Source: Endologix

Endologix Reports 25% Revenue Growth for the Third Quarter 2013

IRVINE, Calif., Oct. 30, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three...
October 14, 2013 09:00 ET | Source: Endologix

Endologix to Report Third Quarter 2013 Financial Results on October 30, 2013

IRVINE, Calif., Oct. 14, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the...
September 05, 2013 16:30 ET | Source: Endologix

Endologix to Participate at Two Upcoming Investor Conferences in September

IRVINE, Calif., Sept. 5, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, President...
August 01, 2013 16:15 ET | Source: Endologix

Endologix to Present at the Canaccord Genuity 33rd Annual Growth Conference

IRVINE, Calif., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Shelley Thunen, Chief...
July 30, 2013 16:16 ET | Source: Endologix

Endologix Reports 33% Revenue Growth for the Second Quarter 2013

IRVINE, Calif., July 30, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three...
July 18, 2013 09:00 ET | Source: Endologix

Endologix to Report Second Quarter 2013 Financial Results on July 30, 2013

IRVINE, Calif., July 18, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the...